SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Three Amigos Stock Thread

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sergio H who wrote (27597)12/16/2001 7:05:17 PM
From: Crossy  Read Replies (1) of 29382
 
Sergio,

you say "I am surprised that Sigma-Tau hasn't shorted QSC as a hedge or arbitrage against the warrants"

Well they are a PHARMA company, not an investment bank or a capital company.

The QSC/SigmaTau partnership looks quite comparable to the AMRN/ELAN tieup. The "bigger pharma" wants to grow its investment not playing hedge games. This is about vertical market "seed" financing of a strategic investor, not the beancounter shorters (against the box) wanting to get riskless 5%.

Another fact to consider is that if QSC is to be moved to a "major" exchange (NASDAQ or NYSE) you have those bid price requirements - $5 closing bid average for the Nasdaq. Anoher reason not to "play it safe" by shorting against the box but rather to support the investment by buying on the open markt (as the owners of SigmaTau actually bought QSC stock). The 2 million limit in the "standstill" agreement is more than the current rate of purchases by Sigma Tau's owners trended into mid 2003. I think it was drafted in order not to inadvertedly trigger a "change in control" provision

rgrds
CROSSY
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext